Trevi Therapeutics Inc. (TRVI)
Trevi Therapeutics Max Pain By Strike
TRVI trades at $9.92, 24.0% above the near-term max pain of $8 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($3-$8), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Trevi Therapeutics Max Pain By Expiry
Max pain for TRVI shows an upward trend from 3 to 8, suggesting bullish positioning in longer-dated options. The 86% spread signals divergent expectations across timeframes. Most levels below 9.92 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 8 | n/a (n/a) |
| Nov 21, 2025 | 8 | n/a (n/a) |
| Jan 16, 2026 | 6 | n/a (n/a) |
| Apr 17, 2026 | 7 | n/a (n/a) |
| Jan 15, 2027 | 3 | n/a (n/a) |
| Jan 21, 2028 | 3 | n/a (n/a) |